What Is Apriso Used For

How effective is Apriso for Ulcerative Colitis? (past duration, gender, age)

Summary:

Overall ratings: iii.4/5
Long term ratings: 3.5/5

This is a phase IV clinical written report of how effective Apriso (mesalamine) is for Ulcerative colitis and for what kind of people. The study is created by eHealthMe from 39 Apriso users and is updated continuously.

With medical large data and AI algorithms, eHealthMe enables everyone to run phase Four clinical trial to observe adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase Four clinial trails for COVID nineteen vaccines have been added, check here.

On Apr, 24, 2022

39 people are studied for taking Apriso in Ulcerative colitis

What is Apriso?

Apriso has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from iii,103 Apriso users for its effectiveness, alternative drugs and more than.

What is Ulcerative colitis?

Ulcerative colitis (inflammatory bowel affliction (ibd). it causes swelling, ulcerations, and loss of function of the large intestine) is found to be associated with ii,332 drugs and i,720 conditions past eHealthMe.

Overall effectiveness (number of people):

Does Apriso work for your Ulcerative colitis (overall)?

Long term (ane+ years) effectiveness (number of people):

Does Apriso work for your Ulcerative colitis (long term)?

Apriso effectiveness for Ulcerative colitis (number of people):

Overall:

non at all: iii
somewhat: 4
moderate: thirteen
high: 14
very high: five

Long Term:

not at all: 0
somewhat: ii
moderate: 9
high: seven
very high: three

Gender of people who take Apriso for Ulcerative colitis *:

female: 51.28 %
male: 48.72 %

Age of people who take Apriso for Ulcerative colitis *:

0-1: 0.0 %
2-9: 0.0 %
10-19: 5.13 %
twenty-29: 17.95 %
30-39: 20.51 %
40-49: 20.51 %
50-59: 15.38 %
lx+: xx.51 %

Who find Apriso more effective for Ulcerative Colitis?

Gender of people who take Apriso for Ulcerative colitis *:

female: 52.63 %
male: 47.37 %

Age of people who accept Apriso for Ulcerative colitis *:

0-1: 0.0 %
ii-9: 0.0 %
x-19: 10.53 %
20-29: 21.05 %
30-39: 26.32 %
40-49: 10.53 %
50-59: xv.79 %
lx+: xv.79 %

* Approximation just. Some reports may have incomplete information.

Practice you take Apriso?

- You lot can start a phase 4 clinical trial to monitor Apriso safety and effectiveness.

How to use the study?

You can discuss the study with your doc, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of:

Apriso (3,103 reports)

Treatments, associated drugs and conditions:

Ulcerative colitis (112,827 reports)

How the study uses the information?

The report is based on mesalamine (the active ingredients of Apriso) and Apriso (the brand name). Other drugs that have the same active ingredients (eastward.g. generic drugs) are not considered. Dosage of drugs is not considered in the written report neither.

Who is eHealthMe?

With medical large data and proven AI algorithms, eHealthMe provides a platform for everyone to run stage Four clinical trials. We report millions of patients and 5,000 more each day. Results of our real-globe drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our assay results are bachelor to researchers, health intendance professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

Alert: Please DO NOT Terminate MEDICATIONS without kickoff consulting a physician since doing then could exist chancy to your wellness.

DISCLAIMER: All material bachelor on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All data is observation-just. Our phase Four clinical studies lonely cannot establish cause-upshot relationship. Different individuals may answer to medication in dissimilar ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is fabricated to that outcome. The utilize of the eHealthMe site and its content is at your own risk.

If yous utilise this eHealthMe report on publication, please acknowledge information technology with a citation: written report championship, URL, accessed appointment.

Recent studies on eHealthMe:

Norvasc and Sneezing - 5 seconds ago
Diarrhea and Skin Abscess - eight seconds ago
Gaviscon and Oedema - ten seconds ago
Zoloft and Systemic Lupus Erythematosus - 14 seconds ago
Nasonex and Mastication Disorder - nineteen seconds ago